Search Results - Hiroaki Shima
- Showing 1 - 3 results of 3
-
1
Human endoplasmic reticulum oxidoreductin 1‐α is a novel predictor for poor prognosis of breast cancer by Goro Kutomi, Yasuaki Tamura, Tsutomu Tanaka, Toshimitsu Kajiwara, Kazuharu Kukita, Tousei Ohmura, Hiroaki Shima, Tomoko Takamaru, Fukino Satomi, Y. Suzuki, Toshihiko Torigoe, Noriyuki Sato, Koichi Hirata
Published 2013Artigo -
2
Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2<scp>B</scp>‐derived peptide vaccination for advanced pancreatic cancer patients by Hidekazu Kameshima, Tetsuhiro Tsuruma, Goro Kutomi, Hiroaki Shima, Yuji Iwayama, Yasutoshi Kimura, Masahumi Imamura, Toshihiko Torigoe, Akari Takahashi, Yoshihiko Hirohashi, Yasuaki Tamura, Tomohide Tsukahara, Takayuki Kanaseki, Noriyuki Sato, Koichi Hirata
Published 2012Artigo -
3
Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma by Hiroaki Shima, Giichiro Tsurita, Satoshi Wada, Yoshihiko Hirohashi, Hiroshi Yasui, Hiroshi Hayashi, Takashi Miyakoshi, Kazue Watanabe, Aiko Murai, Hiroko Asanuma, Serina Tokita, Terufumi Kubo, Munehide Nakatsugawa, Takayuki Kanaseki, Tomohide Tsukahara, Yutaka Nakae, Osamu Sugita, Yoichi M. Ito, Yasunori Ota, Yasutoshi Kimura, Goro Kutomi, Koichi Hirata, Toru Mizuguchi, Kohzoh Imai, Ichiro Takemasa, Noriyuki Sato, Toshihiko Torigoe
Published 2019Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Adjuvant
Antigen
Cancer
Cancer research
Epitope
Immunology
Oncology
Pathology
Peptide vaccine
Vaccination
Alternative medicine
Artificial intelligence
Biology
Breast cancer
CD8
CTL*
Cancer vaccine
Cell biology
Clinical endpoint
Computer science
ELISPOT
Endoplasmic reticulum
Gastroenterology
HERO
Immune system
Immunotherapy
Metastasis
Multivariate analysis